Paul Tudor Jones Jazz Pharmaceuticals PLC Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$115.19 - $132.77 $835,818 - $963,379	-7,256 Reduced 22.02%	25,702 $3.1 Million
Q4 2023 Feb 14, 2024	BUY	$114.26 - $136.0 $2.84 Million - $3.37 Million	24,814 Added 304.69%	32,958 $4.05 Million
Q3 2023 Nov 15, 2023	SELL	$122.0 - $145.31 $1.21 Million - $1.44 Million	-9,909 Reduced 54.89%	8,144 $1.05 Million
Q2 2023 Aug 14, 2023	BUY	$122.5 - $147.16 $2.21 Million - $2.66 Million	18,053 New	18,053 $2.24 Million
Q4 2022 Feb 14, 2023	SELL	$129.72 - $159.85 $161,371 - $198,853	-1,244 Reduced 4.97%	23,795 $3.79 Million
Q3 2022 Nov 14, 2022	SELL	$126.59 - $161.18 $699,916 - $891,164	-5,529 Reduced 18.09%	25,039 $3.34 Million
Q2 2022 Aug 15, 2022	BUY	$141.59 - $168.66 $3.27 Million - $3.89 Million	23,092 Added 308.88%	30,568 $4.77 Million
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $489,779 - $607,124	3,778 Added 102.16%	7,476 $1.16 Million
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $890,154 - $1.08 Million	-7,426 Reduced 66.76%	3,698 $471,000
Q3 2021 Nov 15, 2021	BUY	$128.64 - $184.79 $1.43 Million - $2.06 Million	11,124 New	11,124 $1.45 Million
Q2 2021 Aug 16, 2021	SELL	$160.2 - $186.42 $410,272 - $477,421	-2,561 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$150.19 - $173.5 $384,636 - $444,333	2,561 New	2,561 $421,000
Q3 2020 Nov 16, 2020	SELL	$105.46 - $144.13 $279,890 - $382,521	-2,654 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$95.68 - $121.88 $3.18 Million - $4.05 Million	-33,198 Reduced 92.6%	2,654 $293,000
Q1 2020 May 15, 2020	SELL	$87.74 - $152.74 $1.17 Million - $2.03 Million	-13,292 Reduced 27.05%	35,852 $3.58 Million
Q4 2019 Feb 14, 2020	BUY	$117.65 - $153.73 $5.78 Million - $7.55 Million	49,144 New	49,144 $7.34 Million
Q3 2019 Nov 14, 2019	SELL	$125.18 - $143.24 $2.43 Million - $2.78 Million	-19,380 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$125.55 - $144.48 $9,667 - $11,124	-77 Reduced 0.4%	19,380 $2.76 Million
Q1 2019 May 15, 2019	SELL	$121.81 - $142.95 $306,230 - $359,376	-2,514 Reduced 11.44%	19,457 $2.78 Million
Q4 2018 Feb 14, 2019	BUY	$115.94 - $166.74 $2.55 Million - $3.66 Million	21,971 New	21,971 $2.72 Million
Q3 2018 Nov 14, 2018	SELL	$161.01 - $180.57 $237,328 - $266,160	-1,474 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$146.33 - $183.18 $215,690 - $270,007	1,474 New	1,474 $254,000
Q1 2018 May 15, 2018	SELL	$135.59 - $157.16 $1.94 Million - $2.25 Million	-14,313 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$131.06 - $150.39 $1.88 Million - $2.15 Million	14,313	14,313 $1.93 Million

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account